Yatharth Hospital & Trauma Care Services Limited held its 19th Annual General Meeting (AGM) on Friday, September 25, 2026, via video conferencing. The meeting was presided over by Mr. Yatharth Tyagi, Whole-time Director, in the absence of Chairman Dr. Ajay Kumar Tyagi.

Shareholders approved several key resolutions, including the adoption of audited financial statements for FY26 and the re-appointment of Dr. Ajay Kumar Tyagi as a director retiring by rotation. Significant approvals included the ratification of the cost auditor's remuneration for FY27 and consent for a material related party transaction.

Key shareholder approvals

The AGM focused on governance updates and employee incentive structures. Two special resolutions were passed to support long-term growth and talent retention:

• Modification of IPO proceeds: Approval was granted for the modification or revision of the objects and terms of utilisation of Initial Public Offering (IPO) proceeds.
• New ESOP Scheme: The Yatharth Hospital & Trauma Care Services Employee Stock Option Scheme - 2026 was approved. This includes the grant of options to employees of subsidiary companies in India under this scheme.

Meeting proceedings and attendance

The quorum requirement was met with members participating through remote e-voting and live e-voting during the session. The Company Secretary confirmed that there were no qualifications in the Statutory Auditor's Report or Secretarial Auditor's Report for the period.

Key management personnel present included Mr. Amit Kumar Singh (Group CEO), Mr. Pankaj Prabhakar (Group CFO), and Mr. Nitin Gupta (Group COO). Independent Directors Mrs. Promila Bhardwaj, Dr. Mukesh Sharma, Dr. Sanjeev Upadhyaya, and Mr. Ramesh Krishnan attended virtually.

What the Numbers Show

While all resolutions were passed with the requisite majority, voting patterns revealed significant divergence between promoter and institutional investor sentiment on specific items. For the approval of the Employee Stock Option Scheme - 2026, public institutions voted 83.85% against the resolution, casting 12,086,281 votes against compared to 2,327,936 in favour. In contrast, promoters voted unanimously in favour. Similarly, for the material related party transaction, public institutions cast 39.43% of their votes against the proposal, indicating substantial institutional skepticism regarding related-party dealings despite their eventual approval.

Yatharth Hospital & Trauma Care Services Limited announced its participation in two key investor engagement events in Mumbai during late September 2026. The hospital chain will feature at the Nuvama Emerging India CEO Forum on Monday, September 28, followed by sell-side meetings on Tuesday, September 29.

The company filed an intimation with stock exchanges under Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These disclosures ensure transparency regarding management interactions with the investment community.

Event Schedule

The management team will engage with analysts and investors through both conference presentations and direct one-to-one sessions. The specific details of the scheduled events are outlined below:

Compliance and Disclosure

The company stated that no unpublished price sensitive information (UPSI) would be shared during these interactions. This adherence to regulatory norms ensures a level playing field for all market participants. The schedule remains subject to change based on exigencies from either the investors or the company side.

Investors can access further details via the company's official website under the corporate announcements section. The filing was signed by Ritesh Mishra, Company Secretary & Compliance Officer.